Aaron Gerds, MD, department of hematology and medical oncology, Cleveland Clinic, describes the benefits and pitfalls of Twitter as a platform for doctors to share their ideas and engage in the "ultimate peer-review process."

Ishwaria Subbiah, MD, MS, explains the value of having a dedicated team for oncology patient symptom management and demonstrates how using “supportive care” rather than “palliative care” can impact referrals.

Ishwaria Subbiah, MD, MS, explains the value of having a dedicated team for oncology patient symptom management and demonstrates how using “supportive care” rather than “palliative care” can impact referrals.

At the Oncology Clinical Pathways Congress, Chadi sat down with Robin T Zon, MD, FACP, FASCO; Lee Schwartzberg, MD, FACP; and Tom Valuck, MD, JD, MHSA, to discuss pathway integration in value-based care models, OCM and other APMs, and the increasing role of employers in value-based care and payment.

At the Oncology Clinical Pathways Congress, Chadi sat down with Robin T Zon, MD, FACP, FASCO; Lee Schwartzberg, MD, FACP; and Tom Valuck, MD, JD, MHSA, to discuss pathway integration in value-based care models, OCM and other APMs, and the increasing role of employers in value-based care and payment.

Chadi picks the brain of Sayed Tabatabai, MD, a full-time nephrologist and avid writer that attempts to humanize and beautify the patient experience through a variety of written anecdotes in Twitter threads and short stories.

Chadi picks the brain of Sayed Tabatabai, MD, a full-time nephrologist and avid writer that attempts to humanize and beautify the patient experience through a variety of written anecdotes in Twitter threads and short stories.

Chadi makes his rounds at the Oncology Clinical Pathways Congress, catching guests and presenters such as Blase Polite, Alan Balch, and Lee Schwartzberg for some candid conversation and feedback.

Chadi makes his rounds at the Oncology Clinical Pathways Congress, catching guests and presenters such as Blase Polite, Alan Balch, and Lee Schwartzberg for some candid conversation and feedback.

Bobby Daly, MD, MBA, Memorial Sloan Kettering Cancer Center, breaks down prevalent touch points in oncology clinical pathways, including conflicts of interest on pathway development panels, potential for cost variation due to site of care, and interoperability challenges between vendor pathways and individual EMRs.